Squarepoint
BOLD

Squarepoint’s Boundless Bio BOLD Stock Holding History

Squarepoint’s Portfolio BOLD Stock Details BOLD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-16,374
Closed -$18K – 5081
2026
Q1 		$18K Buy
+16,374
New +$19.1K ﹤0.01% 4178
2025
Q4 		– Sell
-50,771
Closed -$62.4K – 5016
2025
Q3 		$62.4K Buy
50,771
+32,372
+176% +$37.4K ﹤0.01% 4192
2025
Q2 		$18.6K Buy
+18,399
New +$24.4K ﹤0.01% 4393
2025
Q1 		– Sell
-32,182
Closed -$93.3K – 5567
2024
Q4 		$93.3K Buy
32,182
+932
+3% +$2.72K ﹤0.01% 4714
2024
Q3 		$108K Hold
31,250
– – ﹤0.01% 3855
2024
Q2 		$121K Hold
31,250
– – ﹤0.01% 3760
2024
Q1 		$445K Buy
+31,250
New +$445K ﹤0.01% 3129

Other funds holding BOLD

AVM
Arch Venture Management Chicago, Illinois $1.1B AUM 356.62% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $2.19B AUM 374.99% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.95B AUM 773.9% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $38.9B AUM 28.51% 1-Year Est. Return

Squarepoint's BOLD Position: Q2 2026 in Review

Squarepoint sold out of Boundless Bio (BOLD) in Q2 2026, closing a stake of 16,374 shares — an estimated $18K sold.

Squarepoint first reported a position in BOLD in Q1 2024 and held it in 7 quarters. The position peaked at $445K in Q1 2024. 40 funds tracked by Wall St. Rank hold BOLD as of Q2 2026.

  • Squarepoint reported no remaining Boundless Bio position as of Q2 2026 after selling out during the quarter.
  • Squarepoint sold 16,374 Boundless Bio shares in Q2 2026, an estimated $18K.
  • Squarepoint first reported a position in Boundless Bio in Q1 2024 and held it in 7 quarters.
  • Squarepoint's Boundless Bio position peaked at $445K in Q1 2024.
  • 40 funds tracked by Wall St. Rank held Boundless Bio as of Q2 2026.

Based on Squarepoint's 13F filing for Q2 2026, filed 14 Aug 2026.